Deltec Asset Management’s AbbVie ABBV Stock Holding History

Deltec Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-33,070	Closed	-$3.06M	–	177
2018 Q2	$3.06M	Buy	+33,070	New	+$3.23M	0.62%	44
2016 Q2	–	Sell	-24,575	Closed	-$1.4M	–	150
2016 Q1	$1.4M	Sell	24,575 -144,775	-85%	-$8.07M	0.35%	66
2015 Q4	$10M	Sell	169,350 -200	-0.1%	-$11.5K	2.55%	8
2015 Q3	$9.22M	Sell	169,550 -101,950	-38%	-$6.64M	2.28%	9
2015 Q2	$18.2M	Buy	271,500 +97,500	+56%	+$6.37M	4.01%	5
2015 Q1	$10.2M	Buy	+174,000	New	+$10.5M	2.22%	10
2014 Q4	–	Sell	-180,500	Closed	-$10.4M	–	141
2014 Q3	$10.4M	Buy	+180,500	New	+$10M	2.34%	10

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deltec Asset Management's ABBV Position: Q3 2018 in Review

Deltec Asset Management sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 33,070 shares — an estimated $3.06M sold.

Deltec Asset Management first reported a position in ABBV in Q3 2014 and held it in 7 quarters. The position peaked at $18.2M in Q2 2015. 1,957 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

Deltec Asset Management reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
Deltec Asset Management sold 33,070 AbbVie shares in Q3 2018, an estimated $3.06M.
Deltec Asset Management first reported a position in AbbVie in Q3 2014 and held it in 7 quarters.
Deltec Asset Management's AbbVie position peaked at $18.2M in Q2 2015.
1,957 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Deltec Asset Management's 13F filing for Q3 2018, filed 18 Oct 2018.